Universitätsspital Zürich (USZ)

Development of randomized trials in adults with medulloblastoma—the example of eortc 1634-btg/noa-23 (2021) Hau P, Frappaz D, Hovey E, Mccabe MG, Pajtler KW, Wiestler B, Seidel C, et al. Journal article A randomized trial of a transglutaminase 2 inhibitor for celiac disease (2021) Schuppan D, Mäki M, Lundin KE, Isola J, Friesing-Sosnik T, Taavela J, Popp A, et al. Journal article Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question! (2021) Ohashi R, Hartmann A, Martignoni G, Moch H Journal article Prevalence and characteristics of test anxiety in first year anatomy students (2021) Bischofsberger L, Burger PH, Hammer A, Paulsen F, Scholz M, Hammer C Journal article ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology (2021) Corradini S, Alongi F, Andratschke N, Azria D, Bohoudi O, Boldrini L, Bruynzeel A, et al. Journal article ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING (2021) Györfi AH, Matei AE, Fuchs M, Rigau A, Hong X, Honglin Z, Luber M, et al. Conference contribution 68GA-FAPI-04 PET/CT STUDY EXTENSION FOR THE ASSESSMENT OF FIBROBLAST ACTIVATION AND RISK EVALUATION IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Conference contribution PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING (2021) Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, et al. Conference contribution Survey within the German Society for Radiation Oncology (DEGRO) on the Diagnosis and Treatment of Salivary Gland Carcinomas (2021) Von Der Gruen J, Roedel C, Balermpas P, Martin D, Semrau S, Fietkau R, Haderlein M Conference contribution Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution